Aurora Cannabis Inc. ACB.TO

Company Overview

Aurora Cannabis Inc. is a Canadian cannabis company focused on the production, distribution, and commercialization of medical cannabis and consumer cannabis products. The company operates primarily in the regulated cannabis industry, with activities spanning cultivation, product development, manufacturing, and international distribution. Aurora generates revenue through medical cannabis sales, consumer recreational cannabis products, and international exports, with medical cannabis representing an increasingly significant portion of its business mix in recent years. Its product portfolio includes dried cannabis flower, oils, vapes, edibles, concentrates, and pharmaceutical-style medical cannabis products sold under multiple consumer and medical brands.

Aurora was founded in 2006 and became publicly traded in Canada before later listing on the Nasdaq under the ticker ACB. The company expanded aggressively during the early years of Canadian cannabis legalization through facility construction and acquisitions, including the acquisitions of CanniMed Therapeutics, MedReleaf, and Whistler Medical Marijuana Corporation. Following industry-wide oversupply and pricing pressure in the Canadian recreational market, Aurora shifted strategic focus toward higher-margin medical cannabis operations, international markets, and operational efficiency. The company positions itself through large-scale cultivation expertise, international medical cannabis infrastructure, and participation in regulated pharmaceutical-oriented cannabis markets.